Press releases
A New Role for IL-33 in Platelet Biology
IPBS is delighted to announce the publication of groundbreaking research led by Dr. Emma Lefrançais in the journal Blood Advances,
30 January 2026
Home
IPBS
Toulouse
Better understanding towards better therapeutics in Cancer, Infection and Inflammation.
News
Charlotte Vaysse elected Toulousian of the Year 2025: recognition for research and innovation against breast cancer
5IPBS is very proud to congratulate Charlotte Vaysse, Professor of Medicine and Hospital Practitioner (PU-PH) at Toulouse University Hospital (CHU),
23 January 2026
News
Launch of the LAM4RO project in Madagascar: a new step forward for tuberculosis diagnosis
IPBS is proud to announce the official launch of the LAM4RO project, “LipoArabinoMannane For Operational Research”, which took place on
23 January 2026
News
10 Years of France–Argentina Scientific Collaboration on Tuberculosis/HIV Co-Infection
On January 16, 2026, the Institute of Pharmacology and Structural Biology (IPBS) hosted the closing meeting of the France–Argentina MAC-TB/HIV
21 January 2026
Agenda
Journée Cytiva
IPBS-Toulouse, Seminar room
Dr. Ludger Johannes - GlycoSwitch — a novel signaling circuit to control endocytosis
IPBS-Toulouse, Seminar room
Prof. Peter Tonge - Kinetic Selectivity – A Missed Opportunity in Drug Discovery?
IPBS-Toulouse, Seminar room
Featured publications (2025-2026)
Dufrançais et al. (2025) Moesin controls cell-cell fusion and osteoclast function. J Cell Biol 224(11):e202409169
Valderrama*, Horlacher*, Publicola* et al. (2026) Optimizing the antibiotic potency and metabolic stability of pyridomycin using a semi-synthetic approach. J Med Chem DOI: 10.1021/acs.jmedchem.5c02409
Gelon et al. (2026) The alarmin Interleukin-33 modulates platelet proteome, function and biogenesis. Blood Adv DOI: 10.1182/bloodadvances.2025018363
Frit*, Amin*, Zahid*, Barboule* et al. (2025) Structural and functional insights into the interaction between Ku70/80 and Pol X family polymerases in NHEJ. Nat Commun 16(1):4208
Blanchard*, Vina* et al. (2025) Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade. Cell Rep Med
Le Mouëllic et al. (2025) Inorganic sulfate is critical for Mycobacterium tuberculosis lung tissue colonization and redox balance. Proc Natl Acad Sci USA 122 (39) e2503966122
de Caro et al. (2025) New effective and less painful high frequency electrochemotherapy protocols: From optimization on 3D models to pilot study on veterinary patients. J Control Release 381:113592
Gorse*, Plessis*, Wearne*, Paradis*, Pinilla*, Chua* et al. (2025) Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation. EMBO Mol Med DOI: 10.1038/s44321-025-00197-4
Kralj et al. (2025) Dynamically assembling magnetic nanochains as new generation of swarm-type magneto-mechanical nanorobots affecting biofilm integrity. Adv Healthc Mater DOI: 10.1002/adhm.202403736
About
the IPBS
The IPBS is a joint research center of the CNRS and the University of Toulouse. Occupying 12,000 m2 in the heart of the main campus of the University of Toulouse III-Paul Sabatier, which offers high-level multidisciplinary training in the fields of science, health and engineering, the IPBS is part of one of the most important scientific research poles in health and biological sciences in France.
Staff
0
Research teams
0
CNRS International Actions
0
running
European grants
European grants
0
Nationalities
0
M2 of laboratories
0
You wish to work on cancer, infectious or inflammatory diseases, with cutting-edge approaches in cellular, molecular and structural biology, in a rich and stimulating environment?
Join us!
Join us!
READY TO COLLABORATE ?